Ding L - Search Results

1

MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer.

Luo LJ, Yang F, Ding JJ, Yan DL, Wang DD, Yang SJ, Ding L, Li J, Chen D, Ma R, Wu JZ, Tang JH. Luo LJ, et al. Among authors: ding l, ding jj. Gene. 2016 Dec 5;594(1):47-58. doi: 10.1016/j.gene.2016.08.057. Epub 2016 Sep 1. Gene. 2016. PMID: 27593563

2

MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel.

Yang F, Luo LJ, Zhang L, Wang DD, Yang SJ, Ding L, Li J, Chen D, Ma R, Wu JZ, Tang JH. Yang F, et al. Among authors: ding l. Gene. 2017 Feb 5;600:21-28. doi: 10.1016/j.gene.2016.11.037. Epub 2016 Nov 29. Gene. 2017. PMID: 27913185

3

Promising therapeutic role of miR-27b in tumor.

Ding L, Ni J, Yang F, Huang L, Deng H, Wu Y, Ding X, Tang J. Ding L, et al. Among authors: ding x. Tumour Biol. 2017 Mar;39(3):1010428317691657. doi: 10.1177/1010428317691657. Tumour Biol. 2017. PMID: 28351320 Free article. Review.

4

PPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathway.

Ni J, Zhou LL, Ding L, Zhao X, Cao H, Fan F, Li H, Lou R, Du Y, Dong S, Liu S, Wang Z, Ma R, Wu J, Feng J. Ni J, et al. Among authors: ding l. Exp Cell Res. 2017 Dec 15;361(2):246-256. doi: 10.1016/j.yexcr.2017.10.024. Epub 2017 Oct 26. Exp Cell Res. 2017. PMID: 29080795

5

Efatutazone and T0901317 exert synergistically therapeutic effects in acquired gefitinib-resistant lung adenocarcinoma cells.

Ni J, Zhou LL, Ding L, Zhang XQ, Zhao X, Li H, Cao H, Liu S, Wang Z, Ma R, Wu J, Feng J. Ni J, et al. Among authors: ding l. Cancer Med. 2018 May;7(5):1955-1966. doi: 10.1002/cam4.1440. Epub 2018 Mar 23. Cancer Med. 2018. PMID: 29573196 Free PMC article.

6

A novel Met-IR-782 near-infrared probe for fluorescent imaging-guided photothermal therapy in breast cancer.

Wu Y, Zhang W, Xu D, Ding L, Ma R, Wu JZ, Tang JH. Wu Y, et al. Among authors: ding l. Lasers Med Sci. 2018 Sep;33(7):1601-1608. doi: 10.1007/s10103-018-2532-7. Epub 2018 Jun 9. Lasers Med Sci. 2018. PMID: 29948451

7

Circular RNA circASS1 is downregulated in breast cancer cells MDA-MB-231 and suppressed invasion and migration.

Hou JC, Xu Z, Zhong SL, Zhang HD, Jiang LH, Chen X, Zhu LP, Li J, Zhou SY, Yang SJ, He YJ, Wang DD, Deng F, Zhang Q, Wang JY, Hu JH, Zhang W, Wu Y, Ding L, Zhao JH, Tang JH. Hou JC, et al. Among authors: ding l. Epigenomics. 2019 Feb;11(2):199-213. doi: 10.2217/epi-2017-0167. Epub 2019 Jan 18. Epigenomics. 2019. PMID: 30657346

8

MiR-101: a potential therapeutic target of cancers.

Wang CZ, Deng F, Li H, Wang DD, Zhang W, Ding L, Tang JH. Wang CZ, et al. Among authors: ding l. Am J Transl Res. 2018 Nov 15;10(11):3310-3321. eCollection 2018. Am J Transl Res. 2018. PMID: 30662588 Free PMC article. Review.

9

Prussian blue-modified ferritin nanoparticles for effective tumor chemo-photothermal combination therapy via enhancing reactive oxygen species production.

Li H, Zhang W, Ding L, Li XW, Wu Y, Tang JH. Li H, et al. Among authors: ding l. J Biomater Appl. 2019 Apr;33(9):1202-1213. doi: 10.1177/0885328218825175. Epub 2019 Feb 2. J Biomater Appl. 2019. PMID: 30714472

10

Addition of Capecitabine in Breast Cancer First-line Chemotherapy Improves Survival of Breast Cancer Patients.

Xu D, Chen X, Li X, Mao Z, Tang W, Zhang W, Ding L, Tang J. Xu D, et al. Among authors: ding l. J Cancer. 2019 Jan 1;10(2):418-429. doi: 10.7150/jca.29739. eCollection 2019. J Cancer. 2019. PMID: 30719136 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,728 results

Search Page